Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Brain Neoplasms 2Prostatic Neoplasms 1Prostate Lesions 1Oligodendroglioma 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 4Temozolomide 3Radiotherapy 2vocimagene amiretrorepvec 1gallium Ga 68 dotatate 1cabazitaxel 1Valproic Acid 1Trail Making Test 1Radiosurgery 1Radiation 1Proton Magnetic Resonance Spectroscopy 1Procarbazine 1OKN 007 1Neuropsychological Tests 1N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine 1Magnetic Resonance Imaging 1Isotretinoin 1Irinotecan 1Gadolinium DTPA 1Fluorescein 1Filgrastim 1Equipment and Supplies 1Drug Therapy 1DNA 1Corticotropin-Releasing Hormone 1Carboplatin 1Biopsy 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Astrocytoma × Magnetic Resonance Imaging × Clear all
NCT00433472 2015-07-29

MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Withdrawn
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡